Table 2.
Univariate and multivariate Cox regression analyses for overall survival of gastric cancer patients.
| Predictor | Univariate Analysis | Multivariate Analysis | ||
|---|---|---|---|---|
| HR(95% CI) | P | HR(95% CI) | P | |
| Age, years | ||||
| ≥65 vs <65 | 1.214(0.786–1.875) | 0.381 | ||
| Gender | ||||
| Female vs Male | 1.430(0.897–2.280) | 0.133 | ||
| Size, cm | ||||
| >4 cm vs ≤4 cm | 1.707(1.054–2.765) | 0.030 | 1.549(0.949–2.527) | 0.080 |
| Tumour location | ||||
| Middle 1/3 vs Upper 1/3 | 0.867(0.397–1.893) | 0.721 | ||
| Lower 1/3 vs Upper 1/3 | 0.701(0.379–1.297) | 0.258 | ||
| More than 2/3 stomach vs Upper 1/3 | 1.058(0.524–2.139) | 0.874 | ||
| pT stagea | ||||
| pT3-4 vs pT1-2 | 0.935(0.430–2.030) | 0.864 | ||
| pN stagea | ||||
| pN+ vs pN0 | 2.095(1.177–3.730) | 0.012 | 1.729(0.956–3.125) | 0.070 |
| Lauren type | ||||
| Diffuse vs Intestinal | 1.095(0.662–1.809) | 0.724 | ||
| Expression of EGLN3 | ||||
| Low vs High | 2.077(1.234–3.496) | 0.006 | 1.905(1.122–3.235) | 0.017 |
apT and pN stage is defined using the American Joint Committee on Cancer (AJCC) Staging System, 8th Edition.